Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV ‐8‐negative multicentric Castleman disease
Open accessAbstract
Multicentric Castleman disease (MCD) describes a heterogeneous group of disorders involving systemic inflammation, characteristic lymph node histopathology, and multi‐organ dysfunction because of pathologic hypercytokinemia. Whereas Human Herpes Virus‐8 (HHV‐8) drives the hypercytokinemia in a cohort of immunocompromised patients, the etiology of HHV‐8‐negative MCD is idiopathic (iMCD). Recently, a limited series of iMCD cases in Japan sharing a constellation of clinical features, including thrombocytopenia (T), anasarca (A), fever (F), reticulin fibrosis (R), and organomegaly (O) has been described as TAFRO syndrome. Herein, we report clinicopathological findings on 25 patients (14 males and 11 females; 23 Japanese‐born and two US‐born), the largest TAFRO syndrome case series, including the first report of cases from the USA. The median age of onset was 50 years old (range: 23–72). The frequency of each feature was as follows: thrombocytopenia (21/25), anasarca (24/25), fever (21/25), organomegaly (25/25), and reticulin fibrosis (13/16). These patients frequently demonstrated abdominal pain, elevated serum alkaline phosphatase levels, and acute kidney failure. Surprisingly, none of the cases demonstrated marked hypergammoglobulinemia, which is frequently reported in iMCD. Lymph node biopsies revealed atrophic germinal centers with enlarged nuclei of endothelial cells and proliferation of endothelial venules in interfollicular zone. 23 of 25 cases were treated initially with corticosteroids; 12 patients responded poorly and required further therapy. Three patients died during the observation period (median: 9 months) because of disease progression or infections. TAFRO syndrome is a unique subtype of iMCD that demonstrates characteristic clinicopathological findings. Further study to clarify prognosis, pathophysiology, and appropriate treatment is needed. Am. J. Hematol. 91:220–226, 2016. © 2015 Wiley Periodicals, Inc.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Patients with the TAFRO subtype of idiopathic multicentric Castleman's disease tend to have the most severe cytokine storm.
“Patients with the thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) subtype tend to have the most severe cytokine storm.79”
From Cytokine storm (2020) · cites this paper as [79]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
Kanda, Y. (2012) · Bone Marrow Transplantation · doi:10.1038/bmt.2012.244 · Cited by 18,876 · see citing works
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519 · see citing works
European consensus on grading bone marrow fibrosis and assessment of cellularity.
Thiele, J., Kvasnicka, H. M., Facchetti, F., Franco, V., van der Walt, J. D., & Orazi, A. (2005) · PubMed · Cited by 762 · see citing works
Interleukin-6 is a potent thrombopoietic factor in vivo in mice
Ishibashi, T., Kimura, H., Shikama, Y., Uchida, T., KARIYONE, S., Hirano, T., Kishimoto, T., Takatsuki, F., & Akiyama, Y. (1989) · Blood · doi:10.1182/blood.v74.4.1241.1241 · Cited by 431 · see citing works
Oksenhendler, E., Boulanger, E., Galicier, L., Du, M., Dupin, N., Diss, T., Hamoudi, R., Daniel, M., Agbalika, F., Boshoff, C., et al. (2002) · Blood · doi:10.1182/blood.v99.7.2331 · Cited by 421 · see citing works
Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro.
Ishibashi, T., Kimura, H., Uchida, T., KARIYONE, S., Friese, P., & Burstein, S. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5953 · Cited by 406 · see citing works
Frizzera, G., Peterson, B. A., Bayrd, E. D., & Goldman, A. I. (1985) · Journal of Clinical Oncology · doi:10.1200/jco.1985.3.9.1202 · Cited by 380 · see citing works
Surgery in Castleman's Disease
Talat, N., Belgaumkar, A. P., & Schulte, K. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e318249dcdc · Cited by 358 · see citing works
Fajgenbaum, D. C., van Rhee, F., & Nabel, C. S. (2014) · Blood · doi:10.1182/blood-2013-12-545087 · Cited by 336 · see citing works
Self-citationUldrick, T. S., Wang, V., O’Mahony, D., Aleman, K. O., Wyvill, K. M., Marshall, V. A., Steinberg, S. M., Pittaluga, S., Marić, I., Whitby, D., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/654798 · Cited by 304 · see citing works
A systemic lymphoproliferative disorder with morphologic features of Castlemanʼs disease
Frizzera, G., Massarelli, G., Banks, P. M., & Rosaí, J. (1983) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198304000-00001 · Cited by 283 · see citing works
POEMS syndrome: 2021 Update on diagnosis, risk‐stratification, and management
Dispenzieri, A. A. (2021) · American Journal of Hematology · doi:10.1002/ajh.26240 · Cited by 255 · see citing works
Fifty years of multicentric Castleman's disease
Waterston, A. M., & Bower, M. (2004) · Acta Oncologica · doi:10.1080/02841860410002752 · Cited by 205 · see citing works
Eddahri, F., Denanglaire, S., Bureau, F., Spolski, R. J., Leonard, W. J., Léo, O., & Andris, F. (2008) · Blood · doi:10.1182/blood-2008-04-154682 · Cited by 197 · see citing works
Takai, K., Nikkuni, K., Shibuya, H., & Hashidate, H. (2010) · PubMed · Cited by 181 · see citing works
Self-citationPOEMS syndrome: 2014 Update on diagnosis, risk‐stratification, and management
Dispenzieri, A. A. (2014) · American Journal of Hematology · doi:10.1002/ajh.23644 · Cited by 133 · see citing works
How I treat HIV-associated multicentric Castleman disease
Bower, M. (2010) · Blood · doi:10.1182/blood-2010-07-290213 · Cited by 132 · see citing works
Dao, L. N., Hanson, C. A., Dispenzieri, A. A., Morice, W. G., Kurtin, P. J., & Hoyer, J. D. (2011) · Blood · doi:10.1182/blood-2010-11-316935 · Cited by 125 · see citing works
Dispenzieri, A. A. (2012) · Blood · doi:10.1182/blood-2012-03-378992 · Cited by 120 · see citing works
HHV‐8 infection status of AIDS‐unrelated and AIDS‐associated multicentric Castleman's disease
Suda, T., Katano, H., Delsol, G., Kakiuchi, C., Nakamura, T., Shiota, M., Sata, T., Higashihara, M., & Mori, S. (2001) · Pathology international (Print) · doi:10.1046/j.1440-1827.2001.01266.x · Cited by 120 · see citing works
Diehl, S. A., Schmidlin, H., Nagasawa, M., Blom, B., & Spits, H. (2012) · Immunology and Cell Biology · doi:10.1038/icb.2012.17 · Cited by 114 · see citing works
LEVAN, A. (1956) · Cancer · doi:10.1002/1097-0142(195607/08)9:4 · Cited by 110 · see citing works
Kojima, M., Nakamura, N., Tsukamoto, N., Otuski, Y., Shimizu, K., Itoh, H., Kobayashi, S., Kobayashi, H., Murase, T., Masawa, N., et al. (2008) · International Journal of Surgical Pathology · doi:10.1177/1066896908315812 · Cited by 104 · see citing works
Self-citationMasaki, Y., Nakajima, A., Iwao, H. K., Kurose, N., Sato, T., Nakamura, T., Miki, M., Sakai, T., Kawanami, T., Sawaki, T., et al. (2013) · Journal of the Japan Society of the Reticuloendothelial System · doi:10.3960/jslrt.53.79 · Cited by 92 · see citing works
Inoue, M., Ankou, M., Jiang, H., Iwaki, Y., Hagihara, M., & Ota, Y. (2013) · Journal of Clinical and Experimental Hematopathology · doi:10.3960/jslrt.53.95 · Cited by 79 · see citing works
Self-citationChadburn, A., Cesarman, E., Nádor, R. G., Liu, Y. F., & Knowles, D. M. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970815)80:4 · Cited by 74 · see citing works
Kawabata, H., Kotani, S., Matsumura, Y., Kondo, T., Katsurada, T., Haga, H., Kadowaki, N., & Takaori-Kondo, A. (2013) · Internal medicine · doi:10.2169/internalmedicine.52.9482 · Cited by 71 · see citing works
Iwaki, N., Sato, Y., Takata, K., Kondo, E., Ohno, K., Takeuchi, M., Orita, Y., Nakao, S., & Yoshino, T. (2013) · Journal of Clinical and Experimental Hematopathology · doi:10.3960/jslrt.53.87 · Cited by 66 · see citing works
Self-citationTakai, K., Nikkuni, K., Momoi, A., Nagai, K., Igarashi, N., & Saeki, T. (2013) · Journal of the Japan Society of the Reticuloendothelial System · doi:10.3960/jslrt.53.63 · Cited by 61 · see citing works
Self-citationKojima, M., Nakamura, S., Itoh, H., Yoshida, K., Asano, S., Yamane, N., Komatsumoto, S., Ban, S., Joshita, T., & Suchi, T. (1997) · Pathology - Research and Practice · doi:10.1016/s0344-0338(97)80015-5 · Cited by 54 · see citing works
Eruptive Cherry Hemangiomatosis Associated With Multicentric Castleman Disease
Fajgenbaum, D. C., Rosenbach, M. A., van Rhee, F., Nasir, A., & Reutter, J. C. (2013) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.1552 · Cited by 51 · see citing works
Self-citationVenkataraman, G., Uldrick, T. S., Aleman, K. O., O’Mahony, D., Karcher, D. S., Steinberg, S. M., Raffeld, M. A., Marshall, V. A., Whitby, D., Little, R. F., et al. (2013) · American Journal of Clinical Pathology · doi:10.1309/ajcpkgf7u8awqbvg · Cited by 32 · see citing works
Awano, N., Inomata, M., Sonoda, Y., Kondoh, K., Ono, R., Moriya, A., Ando, T., Kumasaka, T., Takemura, T., Takeuchi, K., et al. (2013) · Journal of the Japan Society of the Reticuloendothelial System · doi:10.3960/jslrt.53.101 · Cited by 22 · see citing works
Bone Marrow Findings in Multicentric Castleman Disease in HIV-negative Patients
Kreft, A., Weber, A., Springer, E., Heß, G., & Kirkpatrick, C. J. (2007) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213382.40289.68 · Cited by 20 · see citing works
First European Case of TAFRO Syndrome Associated with Sjogren Disease
Abdo, L. A. (2014) · American Journal of Internal Medicine · doi:10.11648/j.ajim.20140206.12 · Cited by 19 · see citing works
Fajgenbaum, D. C., Liu, A. Y., Ruth, J. R., Nabel, C., Finkelman, B. S., Kurzrock, R., van Rhee, F., & Rubenstein, A. H. (2014) · Blood · doi:10.1182/blood.v124.21.4861.4861 · Cited by 10 · see citing works
Self-citationAntoine Gessain, A. (1998) · PubMed · Cited by 9 · see citing works
Flagged first, then by citations
1 of the 39 references couldn’t be matched to a known paper.
Research works printed but not linked: 5
- Chadburn A, Cesarman E, Nador RG, Liu YF, Knowles DM. Kaposi's sarcoma-associated her- pesvirus sequences in benign lymphoid. Cancer 1997; 80:788-797.
- Gessain A. [Human herpesvirus 8 and associ- ated diseases: Kaposi's sarcoma, body cavity based. Bull Acad Natl Med 1997; 181:1023- 1034.
- Suda T, Katano H, Delsol G, et al. HHV-8 infection status of AIDS-unrelated and AIDS- associated multicentric. Pathol Int 2001; 51:671- 679.
- Takai K, Nikkuni K, Shibuya H, Hashidate H. Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural. Rinsho Ketsueki 2010; 51:320-325.
- Kojima M, Nakamura N, Tsukamoto N, et al. Clinical implications of idiopathic multicentric castleman disease among. Int J Surg Pathol 2008; 16:391-398.
Cited by
Sorted by citations
Fajgenbaum, D. C., & June, C. H. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2026131 · Cited by 3,196 · see citing works
Self-citationFajgenbaum, D., Uldrick, T., Bagg, A., Frank, D. M., Wu, D., Srkalović, G., Simpson, D., Liu, A. Y., Menke, D., Chandrakasan, S., et al. (2017) · Blood · doi:10.1182/blood-2016-10-746933 · Cited by 601 · see citing works
Self-citationDispenzieri, A., & Fajgenbaum, D. C. (2020) · Blood · doi:10.1182/blood.2019000931 · Cited by 487 · see citing works
Self-citationRhee, F. V., Voorhees, P., Dispenzieri, A., Fosså, A., Srkalović, G., Ide, M., Munshi, N., Schey, S., Streetly, M., Pierson, S., et al. (2018) · Blood · doi:10.1182/blood-2018-07-862334 · Cited by 387 · see citing works
Self-citationIdiopathic multicentric Castleman's disease: a systematic literature review
Liu, A. Y., Nabel, C. S., Finkelman, B. S., Ruth, J. R., Kurzrock, R., van Rhee, F., Krymskaya, V. P., Kelleher, D. P., Rubenstein, A. H., & Fajgenbaum, D. C. (2016) · The Lancet Haematology · doi:10.1016/s2352-3026(16)00006-5 · Cited by 331 · see citing works
Self-citationThe full spectrum of Castleman disease: 273 patients studied over 20 years
Oksenhendler, E., Boutboul, D., Fajgenbaum, D., Mirouse, A., Fieschi, C., Malphettes, M., Vercellino, L., Meignin, V., Gérard, L., & Galicier, L. (2018) · British Journal of Haematology · doi:10.1111/bjh.15019 · Cited by 198 · see citing works
Self-citationClinical and pathological characteristics of HIV- and HHV-8–negative Castleman disease
Li, Y., Tu, M., Cortes, J. E., Xu-Monette, Z. Y., Miranda, R. N., Zhang, J., Orlowski, R. Z., Neelapu, S. S., Boddu, P. C., Akosile, M., et al. (2017) · Blood · doi:10.1182/blood-2016-11-748855 · Cited by 187 · see citing works
Self-citationPathology of Castleman Disease
Wu, D., Lim, M. S., & Jaffe, E. S. (2017) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.09.004 · Cited by 185 · see citing works
Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes
England, J. T., Abdulla, A., Biggs, C. M., Lee, A. Y. Y., Hay, K. A., Hoiland, R. L., Wellington, C. L., Sekhon, M. S., Jamal, S., Shojania, K., et al. (2020) · Blood Reviews · doi:10.1016/j.blre.2020.100707 · Cited by 178 · see citing works
Nishimura, Y., Fajgenbaum, D. C., Pierson, S. K., Iwaki, N., Nishikori, A., Kawano, M., Nakamura, N., Izutsu, K., Takeuchi, K., Nishimura, M. F., et al. (2021) · American Journal of Hematology · doi:10.1002/ajh.26292 · Cited by 138 · see citing works
Self-citation2019 Updated diagnostic criteria and disease severity classification for TAFRO syndrome
Masaki, Y., Kawabata, H., Takai, K., Tsukamoto, N., Fujimoto, S., Ishigaki, Y., Kurose, N., Miura, K., Nakamura, S., & Aoki, S. (2019) · International Journal of Hematology · doi:10.1007/s12185-019-02780-1 · Cited by 137 · see citing works
Self-citationNovel insights and therapeutic approaches in idiopathic multicentric Castleman disease
Fajgenbaum, D. C. (2018) · Blood · doi:10.1182/blood-2018-05-848671 · Cited by 130 · see citing works
Self-citationEpidemiology of Castleman Disease
Simpson, D. (2017) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.09.001 · Cited by 125 · see citing works
Multicentric Castleman disease: Where are we now?
Wang, H., Pittaluga, S., & Jaffe, E. S. (2016) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2016.05.006 · Cited by 122 · see citing works
Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?
Fujimoto, S., Sakai, T., Kawabata, H., Kurose, N., Yamada, S., Takai, K., Aoki, S., Kuroda, J., Ide, M., Setoguchi, K., et al. (2019) · American journal of hematology/oncology · doi:10.1002/ajh.25554 · Cited by 99 · see citing works
Self-citationCastleman Disease Pathogenesis
Fajgenbaum, D. C., & Shilling, D. J. (2017) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.09.002 · Cited by 107 · see citing works
Self-citationPlasma proteomics identifies a ‘chemokine storm’ in idiopathic multicentric Castleman disease
Pierson, S. K., Stonestrom, A. J., Shilling, D., Ruth, J., Nabel, C. S., Singh, A., Ren, Y., Stone, K., Li, H., van Rhee, F., et al. (2018) · American Journal of Hematology · doi:10.1002/ajh.25123 · Cited by 90 · see citing works
Self-citationCastleman disease and TAFRO syndrome
Masaki, Y., Arita, K., Sakai, T., Takai, K., Aoki, S., & Kawabata, H. (2022) · Annals of Hematology · doi:10.1007/s00277-022-04762-6 · Cited by 70 · see citing works
Self-citationTreatment of Idiopathic Castleman Disease
van Rhee, F., Greenway, A. D., & Stone, K. (2017) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.09.008 · Cited by 71 · see citing works
Zhang, L., Zhao, A., Duan, M., Li, Z., Cao, X., Feng, J., Zhou, D., Zhong, D., Fajgenbaum, D. C., & Li, J. (2019) · Blood · doi:10.1182/blood-2018-11-884577 · Cited by 71 · see citing works
Self-citationElevated serum interferon γ-induced protein 10 kDa is associated with TAFRO syndrome
Iwaki, N., Gion, Y., Kondo, E., Kawano, M., Masunari, T., Moro, H., Nikkuni, K., Takai, K., Hagihara, M., Hashimoto, Y., et al. (2017) · Scientific Reports · doi:10.1038/srep42316 · Cited by 67 · see citing works
Self-citationPai, R.-A. L., Japp, A. S., Gonzalez, M., Rasheed, R. F., Okumura, M., Arenas, D., Pierson, S. K., Powers, V., Layman, A. A. K., Kao, C., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.135031 · Cited by 68 · see citing works
Self-citationHatano, Y., Ideta, T., Hirata, A., Hatano, K., Tomita, H., Okada, H., Shimizu, M., Tanaka, T., & Hara, A. (2021) · Cancers · doi:10.3390/cancers13112625 · Cited by 66 · see citing works
García, A. G., Fernández-Martín, J., & Marhuenda, Á. R. (2022) · Rheumatology · doi:10.1093/rheumatology/keac481 · Cited by 63 · see citing works
Nagy, A., Bhaduri, A., Shahmarvand, N., Shahryari, J., Zehnder, J. L., Warnke, R. A., Mughal, T. I., Ali, S. M., & Ohgami, R. S. (2018) · Blood Advances · doi:10.1182/bloodadvances.2017009654 · Cited by 58 · see citing works
Igawa, T., & Sato, Y. (2017) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.09.009 · Cited by 58 · see citing works
Self-citationDistinct features distinguishing IgG4-related disease from multicentric Castleman's disease
Sasaki, T., Akiyama, M., Kaneko, Y., Mori, T., Yasuoka, H., Suzuki, K., Yamaoka, K., Okamoto, S., & Takeuchi, T. (2017) · RMD Open · doi:10.1136/rmdopen-2017-000432 · Cited by 57 · see citing works
Nishikori, A., Nishimura, M. F., Nishimura, Y., Otsuka, F., Maehama, K., Ohsawa, K., Momose, S., Nakamura, N., & Sato, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810301 · Cited by 54 · see citing works
Self-citationMorra, D. E., Pierson, S., Shilling, D. J., Nemat, S., Appiani, C., Guilfoyle, M., Tendler, C., van Rhee, F., & Fajgenbaum, D. (2018) · British Journal of Haematology · doi:10.1111/bjh.15588 · Cited by 52 · see citing works
Self-citationWang, W., & Medeiros, L. J. (2019) · Surgical pathology clinics · doi:10.1016/j.path.2019.03.003 · Cited by 50 · see citing works
Clinical, laboratory and imaging findings in Castleman's disease – The subtype decides
Haap, M. M., Wiefels, J., Horger, M., Hoyer, A., & Müssig, K. (2017) · Blood Reviews · doi:10.1016/j.blre.2017.11.005 · Cited by 49 · see citing works
Diagnosis of Castleman Disease
Szalat, R. E., & Munshi, N. C. (2017) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.09.005 · Cited by 49 · see citing works
Dumic, I., Radovanovic, M., Igandan, O., Savić, I., Nordstrom, C. W., Jevtic, D., Subramanian, A., & Ramanan, P. (2020) · American Journal of Case Reports · doi:10.12659/ajcr.926433 · Cited by 47 · see citing works
The clinical picture of Castleman disease: a systematic review and meta-analysis
Hoffmann, C., Oksenhendler, É., Littler, S., Grant, L., Kanhai, K. J. K., & Fajgenbaum, D. C. (2024) · Blood Advances · doi:10.1182/bloodadvances.2024013548 · Cited by 48 · see citing works
Self-citationHistorical and pathological overview of Castleman disease
Nishimura, M. F., Nishimura, Y., Nishikori, A., Yoshino, T., & Sato, Y. (2022) · Journal of the Japan Society of the Reticuloendothelial System · doi:10.3960/jslrt.21036 · Cited by 45 · see citing works
Self-citationTAFRO syndrome: current perspectives
Sakashita, K., Murata, K., & Takamori, M. (2018) · Journal of Blood Medicine · doi:10.2147/jbm.s127822 · Cited by 45 · see citing works
The Clinical and Histopathological Feature of Renal Manifestation of TAFRO Syndrome
Mizuno, H., Sawa, N., Watanabe, S., Ikuma, D., Sekine, A., Kawada, M., Yamanouchi, M., Hasegawa, E., Suwabe, T., Hoshino, J., et al. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2020.05.004 · Cited by 41 · see citing works
Expert Perspective: Diagnosis and Treatment of Castleman Disease
Chen, L. Y. C., Zhang, L., & Fajgenbaum, D. C. (2025) · Arthritis & Rheumatology · doi:10.1002/art.43269 · Cited by 40 · see citing works
Self-citationTAFRO syndrome as a cause of glomerular microangiopathy: a case report and literature review
Nagayama, Y., Yamano, M., Yagame, M., Nariyama, T., Takahashi, M., Kawamoto, M., & Matsui, K. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1574-9 · Cited by 37 · see citing works
José, F. F., Kerbauy, L. N., Perini, G. F., Blumenschein, D. I., Pasqualin, D. D. C., Malheiros, D. M. A. C., Neto, G. D. C. C., Santos, F. P. D. S., Piovesan, R., & Hamerschlak, N. (2017) · Medicine · doi:10.1097/md.0000000000006271 · Cited by 35 · see citing works
TAFRO Syndrome in Caucasians: A Case Report and Review of the Literature
Louis, C., Vijgen, S., Samii, K., Chalandon, Y., Terriou, L., Launay, D., Fajgenbaum, D. C., Seebach, J. D., & Müller, Y. D. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00149 · Cited by 35 · see citing works
Self-citationDong, Y., Zhang, L., Nong, L., Wang, L., Liang, Z., Zhou, D., Fajgenbaum, D. C., Ren, H., & Li, J. (2018) · Annals of Hematology · doi:10.1007/s00277-018-3347-0 · Cited by 34 · see citing works
Self-citationLymphadenopathy in the rheumatology practice: a pragmatic approach
Rodolfi, S., Della‐Torre, E., Bongiovanni, L., Mehta, P., Fajgenbaum, D. C., & Selmi, C. F. (2023) · Rheumatology · doi:10.1093/rheumatology/kead644 · Cited by 34 · see citing works
Self-citationThe critical impacts of cytokine storms in respiratory disorders
Tramboo, S. R., Elkhalifa, A. M. E., Khursheed, S. Q., Ali, S. I., Shah, N. N., Taifa, S., Rakhshan, R., Shah, I. H., Mir, M. A., Malik, M., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29769 · Cited by 31 · see citing works
Fajgenbaum, D. C., Wu, D., Goodman, A. M., Wong, R. S. M., Chadburn, A., Nasta, S. D., Srkalović, G., Mukherjee, S., Leitch, H. A., Jayanthan, R., et al. (2020) · American Journal of Hematology · doi:10.1002/ajh.25992 · Cited by 33 · see citing works
Self-citationTAFRO syndrome: New subtype of idiopathic multicentric Castleman disease
Srkalović, G., Marijanović, I., Srkalovic, M. B., & Fajgenbaum, D. C. (2017) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2017.1930 · Cited by 33 · see citing works
Self-citationSuccessful treatment with tacrolimus in TAFRO syndrome
Shirai, T., Ōnishi, A., Waki, D., Saegusa, J., & Morinobu, A. (2018) · Medicine · doi:10.1097/md.0000000000011045 · Cited by 31 · see citing works
Lust, H., Gong, S., Remiker, A. S., & Rossoff, J. E. (2021) · Pediatric Blood & Cancer · doi:10.1002/pbc.29261 · Cited by 31 · see citing works
The management of Castleman disease
Lomas, O., Streetly, M., Pratt, G., Cavet, J., Royston, D., Schey, S., & Ramasamy, K. (2021) · British Journal of Haematology · doi:10.1111/bjh.17688 · Cited by 26 · see citing works
Candidate biomarkers for idiopathic multicentric Castleman disease
Sumiyoshi, R., Koga, T., & Kawakami, A. (2022) · Journal of Clinical and Experimental Hematopathology · doi:10.3960/jslrt.22010 · Cited by 28 · see citing works
Multicentric Castleman disease and the evolution of the concept
Zhou, T., Wang, H.-W., Pittaluga, S., & Jaffe, E. (2021) · Pathologica · doi:10.32074/1591-951x-351 · Cited by 22 · see citing works
Idiopathic multicentric Castleman disease: An update in diagnosis and treatment advances
Lang, E., & van Rhee, F. (2023) · Blood Reviews · doi:10.1016/j.blre.2023.101161 · Cited by 29 · see citing works
Nishikori, A., Nishimura, M. F., Fajgenbaum, D. C., Nishimura, Y., Maehama, K., Haratake, T., Tabata, T., Kawano, M., Nakamura, N., Momose, S., et al. (2024) · Journal of Clinical Pathology · doi:10.1136/jcp-2023-209280 · Cited by 27 · see citing works
Self-citationSimons, M., Apor, E., Butera, J. N., & Treaba, D. O. (2016) · Case Reports in Hematology · doi:10.1155/2016/4703608 · Cited by 27 · see citing works
Renal histology in a patient with TAFRO syndrome: a case report
Mizuno, H., Sekine, A., Oguro, M., Ôshima, Y., Kawada, M., Sumida, K., Yamanouchi, M., Hayami, N., Suwabe, T., Hiramatsu, R., et al. (2018) · Human Pathology · doi:10.1016/j.humpath.2018.03.021 · Cited by 27 · see citing works
A benefit and the prospects of IL-6 inhibitors in idiopathic multicentric Castleman's disease
Koga, T., Sumiyoshi, R., Kawakami, A., & Yoshizaki, K. (2018) · Modern Rheumatology · doi:10.1080/14397595.2018.1532383 · Cited by 27 · see citing works
TAFRO syndrome: A severe manifestation of Sjogren's syndrome? A systematic review
Grange, L., Chalayer, É., Boutboul, D., Paul, S., Galicier, L., Gramont, B., & Killian, M. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103137 · Cited by 27 · see citing works
Nara, M., Komatsuda, A., Itoh, F., Kaga, H., Saitoh, M., Togashi, M., Kameoka, Y., Wakui, H., & Takahashi, N. (2017) · Internal Medicine · doi:10.2169/internalmedicine.56.7991 · Cited by 26 · see citing works
Noda‐Narita, S., Sumida, K., Sekine, A., Hoshino, J., Mise, K., Suwabe, T., Hayami, N., Yamanouchi, M., Ueno, T., Mizuno, H., et al. (2018) · CEN Case Reports · doi:10.1007/s13730-018-0319-0 · Cited by 26 · see citing works
Yoshimi, A., Trippett, T. M., Zhang, N., Chen, X., Penson, A. V., Arcila, M. E., Pichardo, J. D., Baik, J., Sigler, A. M., Harada, H., et al. (2020) · Oncogene · doi:10.1038/s41388-020-1204-9 · Cited by 25 · see citing works
Self-citationTafro syndrome: Critical review for clinicians and pathologists.
Paydaş, S. (2018) · Critical reviews in oncology/hematology · doi:10.1016/j.critrevonc.2018.05.015 · Cited by 20 · see citing works
Pierson, S. K., Brandstadter, J. D., Torigian, D. A., Bagg, A., Lechowicz, M. J., Alapat, D. V., Casper, C., Chadburn, A., Chandrakasan, S., Dispenzieri, A. A., et al. (2025) · Blood Advances · doi:10.1182/bloodadvances.2024014391 · Cited by 23 · see citing works
Self-citationComputed tomography findings of early-stage TAFRO syndrome and associated adrenal abnormalities
Kurokawa, R., Gonoi, W., Yokota, H., Isshiki, S., Ohira, K., Mizuno, H., Kiguchi, T., Inui, S., Kurokawa, M., Kato, S., et al. (2020) · European Radiology · doi:10.1007/s00330-020-06919-1 · Cited by 23 · see citing works
Yasuda, S., Tanaka, K., Ichikawa, A., Watanabe, K., Uchida, E., Yamamoto, M., Yamamoto, K., Mizuchi, D., Miura, O., & Fukuda, T. (2016) · International Journal of Hematology · doi:10.1007/s12185-016-2025-z · Cited by 23 · see citing works
Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease
Fajgenbaum, D. C. (2018) · Hematology · doi:10.1182/asheducation-2018.1.318 · Cited by 23 · see citing works
Self-citationTocilizumab for the treatment of TAFRO syndrome: a systematic literature review
Akiyama, M., Kaneko, Y., & Takeuchi, T. (2020) · Annals of Hematology · doi:10.1007/s00277-020-04275-0 · Cited by 21 · see citing works
Patient’s age and d-dimer levels predict the prognosis in patients with TAFRO syndrome
Kawabata, H., Fujimoto, S., Sakai, T., Yanagisawa, H., Kitawaki, T., Nara, K., Hagihara, M., Yamamoto, H., Tanimizu, M., Kato, C., et al. (2021) · International Journal of Hematology · doi:10.1007/s12185-021-03159-x · Cited by 20 · see citing works
Self-citationInternational definition of iMCD-TAFRO: future perspectives
Nishimura, Y., Nishimura, M. F., & Sato, Y. (2022) · Journal of the Japan Society of the Reticuloendothelial System · doi:10.3960/jslrt.21037 · Cited by 20 · see citing works
Self-citationSjögren's syndrome manifesting as clinicopathological features of TAFRO syndrome
Fujimoto, S., Kawabata, H., Kurose, N., Iwao, H. K., Sakai, T., Kawanami, T., Fujita, Y., Fukushima, T., & Masaki, Y. (2017) · Medicine · doi:10.1097/md.0000000000009220 · Cited by 20 · see citing works
Successful treatment by tocilizumab without steroid in a very severe case of TAFRO syndrome
Fujiki, T., Hirasawa, S., Watanabe, S., Iwamoto, S., & Ando, R. (2017) · CEN Case Reports · doi:10.1007/s13730-017-0253-6 · Cited by 19 · see citing works
Maisonobe, L., Bertinchamp, R., Damian, L., Gérard, L., Berisha, M., Guillet, S., Fieschi, C., Malphettes, M., Fadlallah, J., Hié, M., et al. (2021) · British Journal of Haematology · doi:10.1111/bjh.17868 · Cited by 19 · see citing works
Serial Manifestation of Acute Kidney Injury and Nephrotic Syndrome in a Patient with TAFRO Syndrome
Ito, S., Uchida, T., Itai, H., Yamashiro, A., Yamagata, A., Matsubara, H., Imakiire, T., Shimazaki, H., Kumagai, H., & Oshima, N. (2018) · Internal Medicine · doi:10.2169/internalmedicine.0806-18 · Cited by 19 · see citing works
Multicentric Castleman disease with TAFRO syndrome and Sjögren's
Li, Z. Y., Shirley, K., Huang, S., & Mian, R. (2019) · Clinical Case Reports · doi:10.1002/ccr3.2502 · Cited by 19 · see citing works
A Rare Lymphoproliferative Disease: Castleman Disease
Gündüz, E., Özdemir, N., Bakanay, Ş. M., & Karakuş, S. (2021) · Turkish Journal of Hematology · doi:10.4274/tjh.galenos.2021.2021.0440 · Cited by 19 · see citing works
Li, Y., Shi, M., Cai, Q., Strati, P., Hagemeister, F. B., Zhai, Q.-L., Li, L., Fang, X., Li, J., Sun, R., et al. (2020) · The Oncologist · doi:10.1634/theoncologist.2019-0986 · Cited by 18 · see citing works
Self-citationTAFRO syndrome: An atypical variant of KSHV ‐negative multicentric C astleman disease
Carbone, A., & Pantanowitz, L. (2015) · American Journal of Hematology · doi:10.1002/ajh.24274 · Cited by 18 · see citing works
Tu, K., Fan, P.-Y., Chen, T., Chuang, W., Wu, C., Ku, C., Tian, Y.-C., Yang, C.-W., Fang, J., & Yang, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126286 · Cited by 17 · see citing works
Belyaeva, E., Rubenstein, A., Pierson, S., Dalldorf, D., Frank, D. M., Lim, M., & Fajgenbaum, D. (2022) · Hematological Oncology · doi:10.1002/hon.2969 · Cited by 12 · see citing works
Self-citationTAFRO syndrome: A disease that known is half cured
Chen, T., Feng, C., Zhang, X., & Zhou, J. (2022) · Hematological Oncology · doi:10.1002/hon.3075 · Cited by 17 · see citing works
Shirakashi, M., Nishida, Y., Nakashima, R., Fujimoto, M., Hiwa, R., Tsuji, H., Kitagori, K., Akizuki, S., Morinobu, A., & Yoshifuji, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-53413-5 · Cited by 17 · see citing works
Fujiwara, Y., Kanae, I. T. O., Takamura, A., & Nagata, K. (2018) · Journal of Medical Case Reports · doi:10.1186/s13256-018-1814-9 · Cited by 17 · see citing works
Nishimura, Y., Hanayama, Y., Fujii, N., Kondo, E., & Otsuka, F. (2019) · Internal Medicine Journal · doi:10.1111/imj.14404 · Cited by 17 · see citing works
Self-citationKurose, N., Mizutani, K., Kumagai, M., Shioya, A., Guo, X., Nakada, S., Fujimoto, S., Kawabata, H., Masaki, Y., Takai, K., et al. (2018) · Pathology - Research and Practice · doi:10.1016/j.prp.2018.12.025 · Cited by 17 · see citing works
Self-citationEndo, Y., Koga, T., Ubara, Y., Sumiyoshi, R., Furukawa, K., & Kawakami, A. (2021) · Clinical and Experimental Immunology · doi:10.1111/cei.13632 · Cited by 13 · see citing works
TAFRO Syndrome: A Disease Requiring Immediate Medical Attention
Masaki, Y., Ueda, Y., Yanagisawa, H., Arita, K., Sakai, T., Yamada, K., Mizuta, S., Fukushima, T., Takai, K., Aoki, S., et al. (2022) · Internal Medicine · doi:10.2169/internalmedicine.9622-22 · Cited by 16 · see citing works
Self-citationCoutier, F., MÉAUX-RUAULT, N., Crépin, T., Bouiller, K., Gil, H., Humbert, S., Bedgedjian, I., & Magy-Bertrand, N. (2017) · Annals of Hematology · doi:10.1007/s00277-017-3138-z · Cited by 16 · see citing works
Kurose, N., Futatsuya, C., Mizutani, K., Kumagai, M., Shioya, A., Guo, X., Aikawa, A., Nakada, S., Fujimoto, S., Kawabata, H., et al. (2018) · Human Pathology · doi:10.1016/j.humpath.2018.04.001 · Cited by 16 · see citing works
Self-citationNoda, Y., Saka, Y., Kato, A., Mimura, T., & Naruse, T. (2018) · Clinical Nephrology - Case Studies · doi:10.5414/cncs109400 · Cited by 16 · see citing works
Takayama, Y., Kubota, T., Ogino, Y., Ohnishi, H., Togitani, K., & Yokoyama, A. (2017) · Internal Medicine · doi:10.2169/internalmedicine.9484-17 · Cited by 16 · see citing works
Yamada, M., Sada, R. M., Kashihara, E., Okubo, G., Matsushita, S., Manabe, A., Tagawa, S., Akebo, H., Miyake, H., & Hatta, K. (2022) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2022.04.005 · Cited by 15 · see citing works
Hasegawa, E., Sato, H., Wada, Y., Takai, K., Wakamatsu, A., Nozawa, Y., Nakatsue, T., Kuroda, T., Suzuki, Y., Nakano, M., et al. (2017) · Lupus · doi:10.1177/0961203317725589 · Cited by 15 · see citing works
Self-citationZhou, Q., Zhang, Y., Zhou, G., & Zhu, J. (2020) · BMC Nephrology · doi:10.1186/s12882-020-02119-7 · Cited by 15 · see citing works
Inflammatory diseases in hematology: a review
Henrie, R., Cherniawsky, H. M., Marcon, K. M., Zhao, E. J., Marinkovic, A., Pourshahnazari, P., Parkin, S., & Chen, L. Y. C. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00356.2021 · Cited by 16 · see citing works
Matsuhisa, T., Takahashi, N., Nakaguro, M., Sato, M., Inoue, E., Teshigawara, S., Ozawa, Y., Kondo, T., Nakamura, S., Sato, J., et al. (2019) · PubMed Central · doi:10.18999/nagjms.81.3.519 · Cited by 14 · see citing works
Zhou, J., Zhang, L., Liu, X., Zhang, M., Li, J., & Zhang, W. (2023) · CHEST Journal · doi:10.1016/j.chest.2023.03.022 · Cited by 13 · see citing works
Xia, P., Zhang, L., Zou, M., Zhang, T., Li, R., Shi, X., Wang, J., Qin, Y., Li, X., Li, J., et al. (2020) · Kidney & Blood Pressure Research · doi:10.1159/000505458 · Cited by 13 · see citing works
Koga, T., Hagimori, N., Takemori, S., Morimoto, S., Sumiyoshi, R., Shimizu, T., Hosogaya, N., Fukushima, C., Yamamoto, H., & Kawakami, A. (2020) · Medicine · doi:10.1097/md.0000000000020710 · Cited by 13 · see citing works
Nephrotic Syndrome with Thrombocytopenia, Lymphadenopathy, Systemic Inflammation, and Splenomegaly
Nakamori, A., Akagaki, F., Yamaguchi, Y., Arima, R., & Sugiura, T. (2017) · Internal Medicine · doi:10.2169/internalmedicine.9556-17 · Cited by 13 · see citing works
Chisholm, K. M., & Fleming, M. (2020) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaa011 · Cited by 15 · see citing works
Njonnou, S. R. S., Deuson, J., Royer-Chardon, C., Vandergheynst, F. A., & Wilde, V. D. (2020) · BMJ Case Reports · doi:10.1136/bcr-2019-234155 · Cited by 13 · see citing works
- Authors
- Iwaki, N., Fajgenbaum, D. C., Nabel, C. S., Gion, Y., Kondo, E., Kawano, M., Masunari, T., Yoshida, I., Moro, H., Nikkuni, K., Takai, K., Matsue, K., Kurosawa, M., Hagihara, M., Saito, A., Okamoto, M., Yokota, K., Hiraiwa, S., Nakamura, N., Nakao, S., Yoshino, T., & Sato, Y.
- Affiliations
- Kanazawa University (JP)
- University of Pennsylvania (US)
- Okayama University (JP)
- Kanazawa University Hospital (JP)
- Chugoku Central Hospital (JP)
- Shikoku Cancer Center (JP)
- Niigata University (JP)
- Niigata City General Hospital (JP)
- Kameda Medical Center (JP)
- Sapporo National Hospital (JP)
- Eiju General Hospital (JP)
- National Hospital Organization (JP)
- Fujita Health University (JP)
- Tokai University (JP)
- Corresponding author
- Sato, Yasuharu
- ORCID
- Venue
- American Journal of Hematology
- Publisher
- Wiley
- Published
- 2016-01-22
- Volume
- 91
- Issue
- 2
- Pages
- 220-226
- ISSN
- 0361-8609 (ISSN-L)
- 1096-8652
- OpenAlex
- W2179940598
- Cited by
- 296
- References
- 39
- Citations by year
- 2026: 28 · 2025: 30 · 2024: 30 · 2023: 19 · 2022: 31 · 2021: 29 · 2020: 34 · 2019: 23 · 2018: 34 · 2017: 30 · 2016: 7 · 2015: 1
- FWCI
- 10.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- American Journal of Hematology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
- Health Sciences › Medicine › Surgery › Lymphadenopathy Diagnosis and Analysis
- Keywords
- TAFRO syndrome, multicentric Castleman disease, idiopathic multicentric Castleman disease, thrombocytopenia, anasarca, fever, reticulin fibrosis, organomegaly, cytokine storm, lymph node histopathology, endothelial cell proliferation, corticosteroid therapy, acute kidney injury, hypergammaglobulinemia
- MeSH terms
- Adult, Aged, Female, Castleman Disease, Humans, Lymph Nodes, Male, Middle Aged, Plasma Cells, Platelet Count, Syndrome, Thrombocytopenia, Herpesvirus 8, Human, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
